IPHA
Innate Pharma
IPHA
IPHA
8 hedge funds and large institutions have $469K invested in Innate Pharma in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$45.6K |
| 2 |
Optiver Holding
Amsterdam,
Netherlands
|
$169K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$576 |
Top Sellers
| 1 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
$167K |
| 2 |
Jane Street
New York
|
$0 |
| 3 |
Millennium Management
New York
|
$0 |
| 4 |
Morgan Stanley
New York
|
$84.4K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Optiver Holding
Amsterdam,
Netherlands
| $169K | +$32.6K | +16,788 | +24% |
|
|
ETC
2
Exchange Traded Concepts
Oklahoma City,
Oklahoma
| $167K | -$52.1K | -26,833 | -24% |
|
|
3
Morgan Stanley
New York
| $84.4K | -$1.16K | -600 | -1% |
|
|
4
Citadel Advisors
Miami,
Florida
| $45.6K | +$45.6K | +23,527 | New |
|
5
Barclays
London,
United Kingdom
| $1K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $576 | +$169 | +87 | +41% |
|
7
RhumbLine Advisers
Boston,
Massachusetts
| $397 | – | – | – |
|
|
SPIA
8
Steward Partners Investment Advisory
New York
| $388 | – | – | – |
|
|
9
Jane Street
New York
| – | -$41.9K | -14,554 | Closed |
|
|
10
Millennium Management
New York
| – | -$30.5K | -10,579 | Closed |
|